To acquire further high-resolution biological perspectives into tumor progression, it would be necessary to integrate TcB analysis with transcriptomic data (such as bulk sequencing, single cell transcriptomics, etc.), multi-omics (such as metabolomics and proteomics) to generate a dynamic and multi-dimensional biological roadmap of tumor progression corresponding to each tumor type over time. This evidence concerns the gene PKM and neoplasm.